Investor

NeuroVentures

Last cheque observed Mar 2008. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series ASeries BSeries DImpact InvestingTrading Platform

Cheques on record
0%of best year0cheques in 12 months, 9 on record
Since the last cheque6813days00hrs00min00sec
Median round$17MRounds led0 of 9Sole investor1 roundsExits1 from the portfolioMostly inUnited States, 75%
Pitch NeuroVentures

NeuroVentures highlights

  1. 01

    9 rounds on record

  2. 02

    Mostly Series A and Series B: 78% of its rounds

  3. 03

    Sole investor in 1 rounds, median $1.5M

  4. 04

    1 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
Impact InvestingTrading Platform
Cold pitches
Not stated

The record

Every round we can evidence, newest first9 appearances

  1. 2008

    1 round

  2. Mar
    BrainCellsSeries B · US · venturebeat.com$30MWith 5 others
  3. 2007

    1 round

  4. Aug
    NeurAxonSeries B · CA$32MWith 6 others
  5. 2006

    1 round

  6. Aug
    Acumen PharmaceuticalsVenture · US$1.5MSole investor
  7. 2005

    1 round

  8. Jul
    BrainCellsSeries A · US$18MWith 3 others
  9. 2004

    2 rounds

  10. Jul
    NeurAxonSeries A · CA$1.9MWith 2 others
  11. Feb
    Kadmus PharmaceuticalsSeries A · US$15MWith 6 others
  12. 2003

    2 rounds

  13. Nov
    Saegis PharmaceuticalsSeries B · US$30MWith 4 others
  14. Jul
    CyberkineticsSeries A$4.3MWith 2 others
  15. 2001

    1 round

  16. Feb
    Proxima TherapeuticsSeries D · US$17MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

Proxima TherapeuticsBought by Cytyc$160MMar 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as NeuroVentures. A count of rooms they were both in, not a relationship either has claimed.

Oxford Bioscience PartnersGrowth equity3rounds togetherBay City CapitalVC firm2rounds togetherH.I.G. CapitalGrowth equity2rounds togetherTechnology PartnersHedge fund2rounds together

Quick answers about NeuroVentures

What does NeuroVentures invest in?

NeuroVentures invests most often at Series A and Series B (78% of the rounds on record), in sectors such as Impact Investing and Trading Platform.

How active is NeuroVentures?

9 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2008.

How big are NeuroVentures's cheques?

The median round it joins is $17M.

Does NeuroVentures lead rounds?

Rarely, if at all: none of its 9 investments on record names it as the lead.

Where does NeuroVentures invest?

Most of the companies it backs are in the United States (75%) and Canada (25%).

Is NeuroVentures investing now?

No investments in the last 12 months; the latest was in Mar 2008.

Who does NeuroVentures invest alongside?

Most often Oxford Bioscience Partners (3 rounds together), Bay City Capital (2 rounds together) and H.I.G. Capital (2 rounds together).

What kind of investor is NeuroVentures?

NeuroVentures is a VC firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it